CGP 44532, a GABAB receptor agonist, is hedonically neutral and reduces cocaine-induced enhancement of reward

Neuropharmacology

Volumn 42, Issue 5, 2002, Pages 626-632

  Dobrovitsky, V ^a   Pimentel, P ^a   Duarte, A ^a   Froestl, W ^b   Stellar, J R ^a   Trzcinska M ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Brain stimulation reward; CGP 44532; Cocaine; GABA; Intracranial self stimulation; Phosphinic acid analogue

Indexed keywords

4 AMINOBUTYRIC ACID DERIVATIVE; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; CGP 44532; COCAINE; PHOSPHINIC ACID DERIVATIVE; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID B RECEPTOR; DOPAMINE UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; BODY MOVEMENT; BRAIN DEPTH STIMULATION; CONDITIONING; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABUSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SELECTIVITY; GENDER; MALE; METHODOLOGY; NONHUMAN; PATIENT COMPLIANCE; PERFORMANCE; PRIORITY JOURNAL; RAT; RAT STRAIN; REWARD; STIMULUS RESPONSE; THEORY; ADDICTION; ANIMAL; DRUG POTENTIATION; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; REACTION TIME; SPRAGUE DAWLEY RAT;

ANIMALS; BEHAVIOR, ADDICTIVE; COCAINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; GABA AGONISTS; MALE; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RECEPTORS, GABA-B; REWARD;

EID: 0036011170     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(02)00007-2     Document Type: Article

References (53)

1. Ability of baclofen in reducing alcohol craving and intake: II - Preliminary clinical evidence
2. Implication of the GABAB receptor in gamma vinyl-GABA's inhibition of cocaine-induced increases in nucleus accumbens dopamine
3. Novel GABA agonists depress the reward effect of lateral hypothalamic simulation in rats
4. Synergic effects of cocaine with lateral hypothalamic brain stimulation reward: Lack of tolerance or sensitization
5. Control of motor seizures by brotizolam with maintenance of stable refractory periods for self-stimulation
6. (-) Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor
7. B agonist CGP 44532 decreases cocaine self-administration in rats: Demonstration using a progressive ratio and a discrete trials procedure
8. Effect of baclofen on cocaine self-administration in rats reinforced under fixed-ratio 1 and progressive-ratio schedules
9. A microcomputer-based method for physiologically interpretable measurement of the rewarding efficacy of brain stimulation
10. Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats
11. Pharmacotherapies for treatment of cocaine abuse: Preclinical aspects
12. A receptors within the ventral tegmental area
13. B receptors in the basal forebrain selectively impairs working memory of rats in the double Y-maze
14. 11C-Raclopride and positron emission tomography
15. GABAergic attenuation of cocaine-induced dopamine release and locomotor activity
16. A novel strategy for the treatment of cocaine addiction
17. B-receptor activation alters the firing pattern of dopamine neurons in the rat substantia nigra
18. B agonists
19. γ-Aminobutyric acid mimetic drugs differentially inhibit the dopaminergic response to cocaine
20. Potential involvement of anxiety in the neurobiology of cocaine
21. Chlordiazepoxide alters intravenous cocaine self-administration in rats
22. γ-Aminobutyric acid receptor-mediated regulation of periventricular-hypophysial dopaminergic neurons: Possible role in mediating stress- and 5-hydroxytryptamine-induced decreases in neuronal activity
23. Modulation of A10 dopamine neurons by γ-aminobutyric acid agonists
24. Glutamate decarboxylase immunoreactive neurons in rat neostriatum: Their morphological types and populations
25. Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: An in vivo microdialysis study
26. Gamma-vinyl GABA attenuates cocaine-induced lowering of brain stimulation reward thresholds
27. The irreversible γ-aminobutyric acid (GABA) transaminase inhibitor γ-vinyl-GABA blocks cocaine self-administration in rats
28. Baclofen as a cocaine anti-craving medication: A preliminary clinical study
29. Effects of cocaine and GBR-12909 on brain stimulation reward
30. B receptor agonist, dose-dependently impairs spatial learning in rats
31. Management of cocaine abuse and dependence
32. Effects of pharmacologic increases in brain GABA levels on cocaine-induced changes in extracellular dopamine
33. Dopamine-GABA interactions in the nucleus accumbens and lateral septum of the rat
34. Baclofen suppression of cocaine self-administration: Demonstration using a discrete trials procedure
35. Baclofen attenuates the reinforcing effects of cocaine in rats
36. GABA modulation of cocaine self-administration
37. Naltrexone pretreatment decreases the reinforcing effectiveness of ethanol and saccharin but not PCP or food under concurrent progressive-ratio schedules in rhesus monkeys
38. B receptor agonists and antagonists
39. B agonist baclofen modifies cocaine self-administration in rats
40. Dopaminergic agents for the treatment of cocaine abuse
41. Electrophysiological characterization of GABAergic neurons in the ventral tegmental area
42. Effects of peripheral and central dopamine blockade on lateral hypothalamic self-stimulation: Evidence for both reward and motor deficits
43. Pharmacological basis of intracranial self-stimulation reward
44. The projections of the ventral tegmental area and adjacent regions: A combined fluorescent retrograde tracer and immunofluorescence study in the rat
45. Novel monoamine transporter ligands reduce cocaine-induced enhancement of brain stimulation reward
46. GABA-containing neurons in the ventral tegmental area project to the nucleus accumbens in rat brain
47. Relationship between subjective effects of cocaine and dopamine transporter occupancy
48. B and NMDA receptor agonists on medial forebrain bundle self-stimulation
49. Addictive drugs and brain stimulation reward
50. Baclofen inhibits heroin self-administration behavior and mesolimbic dopamine release
51. Opposite changes in the mesolimbic dopamine metabolism in the nerve terminal and cell body sites induced by locally infused baclofen in the rat